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ISEV2019 ABSTRACT BOOK

Since ASCs act predominantly through paracrine
mechanisms, their secretome represents a promising
cell-free alternative. Here we identified anti-hypertrophic and anti-catabolic effects of ASC conditioned
medium (ASC-CM) on TNFα-stimulated human primary articular chondrocytes (CHs).
Methods: CHs were treated with 10 ng/mL TNFα and/
or ASC-CM administered at a 1:5 recipient:donor cell
ratio. Cell viability was assessed up to day 9. The
activity, expression and/or release of hypertrophy markers (MMP-13, Collagen X and Osteocalcin), catabolic
mediators (MMP-3) and cartilage-protective factors
were assessed up to day 3 by enzymatic assays, qRTPCR, Western Blot and multiplex immunoassays.
Results: ASC-CM blunted TNFα-induced hypertrophy,
reducing the enhanced levels of MMP-13 activity
(−61%), Osteocalcin (−37%) and Collagen X (−18%).
In addition, also MMP-3 activity was diminished by
−59%. We associated the observed reduction of MMP3 and MMP-13 activity to the abundancy of TIMPs
(Tissue Inhibitors of MMPs) in ASC secretome, rather
than to a direct down-modulation of their expression
and/or release. Moreover, ASC-CM contains high
levels of OPG and DKK-1, other known chondroprotective factors.
Summary/Conclusion: ASC-CM is rich in cartilageprotective factors and exerts anti-hypertrophic and
anti-catabolic effects on TNFα-stimulated CHs. These
evidences open the way for its possible clinical use as a
cell-free approach in contrasting osteoarthritis. We are
currently investigating through a differential proteomic
analysis if the recognized chondroprotective effectors
are enriched in the vesicular rather than the soluble
component of the secretome.

lineage are likely candidates, thus indicating that MSCs
and the OS stroma cells may be related cell types.
Therefore, this study set out to examine the contribution of EV-mediated intercellular crosstalk of MSC
and OS.
Methods: MSCs and pre-osteoblasts were treated with
OS-EVs at different time points, and the epigenetic
signature of OS-EVs was assessed by LINE-1 and
tumour suppressor genes methylation analysis. In addition, surface markers and gene and expression of specific genes related to bone microenvironment
remodelling (MMP1, VEGF-A, ICAM1) were also
evaluated.
Results: Our data indicated that OS-EVs mediated
LINE-1 hypomethylation in MSCs, whereas an opposite effect was seen in pre-osteoblast, indicating that
MSCs but not pre-osteoblasts were more susceptible to
epigenetic transformation. Thus, OS-EVs dictated the
fate of MSCs by modulating the epigenetic status, and
also influenced the expression of genes related to bone
microenvironment remodelling.
Summary/Conclusion: Overall, this study provided
evidence that epigenetic regulation may appear to be
an early event in the transformation of MSCs.
Elucidating the mechanisms of EV-mediated communication may lead to new avenues for therapeutic
exploitation.
Funding: This research was supported by University of
Helsinki project funding (WBS490302, WBS73714112),
Helsinki University Hospital State funding for university-level health research (Y1014SUL05, TYH2016130),
the Finnish Dental Society Apollonia, Egyptian
Ministry of Higher Education (MoHE) and Selma and
Maja-Lisa Selander foundation.
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Introduction: Extracellular vesicles (EVs) are central to
intercellular communication and play an important
role in cancer progression and development.
Osteosarcoma (OS) is an aggressive bone tumour,
characterized by presence of malignant mesenchymal
cells. Specific tumour-driving genetic alterations associated with OS development are poorly understood.
The cell of origin for OS also remain unknown but
cells of the mesenchymal stem cell (MSC) osteogenic
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Introduction: Neural stem cells (NSC) are known to
facilitate healing of ischemic brain tissues. Recent studies show that NSC derived exosomes function as
paracrine effectors to promote neurovascular remodelling including angiogenesis and axonal outgrowth after
stroke; nevertheless, the contents of the non-stroke and
post stroke NSC exosome proteome and miRNA cargo
have not been determined.

JOURNAL OF EXTRACELLULAR VESICLES

Methods: NSC derived exosomes were purified from
conditioned media of cultured NSCs harvested from
the subventricular zone of non-ischemic and ischemic
rats, respectively. Liquid chromatography mass spectrometry (LCMS) and miRNA array were employed to
comprehensively characterize the protein and miRNA
contents of NSCs and their derived exosomes after
stroke. Bioinformatic analyses were performed using
Ingenuity Pathway Analysis (IPA).
Results: Exosome markers including CD63, CD9, Alix
and size distribution (50–200nm) were verified with
Western blot, transmission electron microscopy
(TEM) and Nanosight, respectively. In total, proteomics analysis yielded 2409 and 1770 proteins identified
in ischemic NSC and NSC derived exosomes, respectively. Bioinformatics analysis identified that 52, 39 and
31 proteins in the NSCs-derived exosomes were related
to regulating neuronal cell proliferation, migration and
differentiation, respectively. In addition, 318 miRNAs
were identified in ischemic NSCs with 26% of miRNAs
(84 miRNAs) overlapped with parent NSCs. Gene
ontology analysis showed that up- and down-regulated
miRNAs with the fold change above 1.5 were highly
related to inflammation, invasion, cell proliferation,
cell cycle, cell death, differentiation, etc. The top three
upregulated miRNAs were validated in ischemic NSCexosomes using real-time RT-PCR.
Summary/Conclusion: Collectively, the results of our
proteomic and miRNA analysis, to our knowledge,
demonstrate for the first time that NSC derived exosomes contain a robust profile of protein and miRNA
effectors. These data provide a platform for beginning
to understand the mechanism by which NSCs are activated after cerebral ischemia, and may lead to a deeper
mechanistic understanding of their role in tissue repair
after neural injury.
Funding: NIH RO1 DK102861, American Heart
Association (AHA) grant 18IPA34170331, NINDS
RO1 NS075156 and RO1 NS088656.
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Introduction: The extracellular vesicles (EVs) derived
from mesenchymal stem cells have been shown to
elicited similar therapeutic effects to their patent cells
in many diseases. However, the difficulties in the largescale preparation of high-purity EVs largely limited its
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clinical application in the future. We sought to apply a
novel anion chromatography for the isolation of iPSCMSC EVs, and explored the effects and mechanisms of
iPSC-MSC EVs in the therapy for asthma.
Methods: The EV-enriched supernatants were collected for the isolation of the iPSC-MSC EVs using
the anion chromatography. The morphologies of EVs
were characterized by transmission electron microscope, the markers of EVs were assayed by western
blot and flow cytometry. The anti-inflammatory effects
of the EVs were determined using the macrophage
assay. Also, the uptake activities of macrophages on
RPF-iPSC-MSC EVs were determined. Finally, the
asthma mouse model was developed and the iPSCMSC EVs were administrated intravenously. The lung
pathology, the levels of inflammatory cytokines in the
bronchoalveolar lavage fluids (BALF) and the polarization of lung macrophages were evaluated.
Results: We successfully obtained concentrated iPSCMSC EVs after the isolation and the final concentration
of EVs was about 200 µg/mL (Bradford) and 10–
15*1011/mL (Nanosight). The iPSC-MSC EVs were
morphologically intact and were positive for the markers including CD9/63/81, Alix and TSG101. Most of
the preparations of iPSC-MSC EVs could significantly
decreased the level of IL-6 in the macrophage assay.
The Raw 264.7 macrophages began to uptake iPSCMSC EVs at 4 h and the uptake activities peaked at
12 h and then receded at 24 h. Also, our in vivo study
showed that splenic macrophages started to uptake
iPSC-MSC EVs at 4 h and the uptake activities were
augmented at 24 h. In addition, the iPSC-MSC EVs
significantly reduced the inflammatory infiltration, the
epithelial goblet cell numbers, the levels of inflammatory cytokines and inflammatory cells in the BALF as
well as the polarizations of pulmonary macrophages.
Summary/Conclusion: Our results showed that the
anion exchange chromatography was a promising
method for the large preparation of iPSC-MSC EVs,
which could possibly be an alternative therapy for
asthma in the future.
Funding: NSFC (81322012, 81373174, 81471832,
81671882 and 81770984)
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